top of page
1-877-KRTL-BIO
Schedule a Consultation
A Wholly Owned Subsidiary of KRTL Holding Group Inc (OTC: KRTL)
Home
About
Services
Clinical & Post Market Support
Quality Control & Quality Assurance
Product Labeling & Compliance
Supply Chain & Logistics
Manufacturing Services
U.S. Agent Representation
Import & Export Logistics
Regulatory Registration & Compliance
News
Knowledge Center
Log In
KRTL NEWS
KRTL HOLDING GROUP INC. REPORTS THIRD QUARTER 2025 RESULTS (UNAUDITED) AND FILES PCAOB-AUDITED 2024 AND 2023 FINANCIAL STATEMENTS
KRTL Holding
Nov 17
KRTL Biotech Highlights Anti-Allergy and Respiratory Product Capabilities to Address Global Market Needs
KRTL Biotech
Nov 6
KRTL Holding Group Highlights Bolivian Innovation CaviGuard, Manufactured by SIGMA, as Global Model in Non-Invasive Dental Care
KRTL Biotech
Nov 4
KRTL Holding Group Congratulates SIGMA on National Recognition for Pharmaceutical Excellence in Bolivia
KRTL Biotech
Oct 30
KRTL Biotech Spotlights Anti-Infectives and Antibiotics Portfolio to Support Public Health and Global Treatment Access
KRTL Biotech
Oct 28
KRTL Biotech Showcases Gastrointestinal Health Portfolio to Address Global Demand for Accessible Digestive Care
KRTL Biotech
Oct 21
Begin Your Journey
bottom of page
